Company Overview
More
Corning Jerry Biopharmaceuticals is an investment holding company, mainly engaged in biopharmaceutical business. The company focuses on R & D, production and commercial innovation of tumor immune biomolecule targeted drugs of the whole industry chain enterprises. The company has a biological innovative drug development technology platform, including protein engineering platform, multi-functional antibody development platform and antibody screening platform. The company conducts business in markets at home and abroad.
CEO： Ting Xu
Market： Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
09966 ALPHAMAB-B
6.880+0.180+2.69%
Market Close 05/17 16:08 CCT
High
7.020
Open
6.830
Turnover
9.36M
Low
6.730
Pre Close
6.700
Volume
1.36M
Price Forecast
Loading...
News
Comment
ALPHAMAB-B: 2021 Annual Report
ALPHAMAB-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021
ALPHAMAB-B: DATE OF BOARD MEETING
ALPHAMAB-B: 2021 INTERIM REPORT
ALPHAMAB-B: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2021
ALPHAMAB-B: DATE OF BOARD MEETING
ALPHAMAB-B: 2020 Annual Report
ALPHAMAB-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020
ALPHAMAB-B: DATE OF BOARD MEETING
ALPHAMAB-B: 2020 Interim Report